Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INNT

Innovate Biopharmaceuticals (INNT) Stock Price, News & Analysis

Innovate Biopharmaceuticals logo

About Innovate Biopharmaceuticals Stock (NASDAQ:INNT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.56
$1.42
52-Week Range
N/A
Volume
1,648 shs
Average Volume
525,982 shs
Market Capitalization
$8 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innovate Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

INNT Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

INNT Stock Analysis - Frequently Asked Questions

Innovate Biopharmaceuticals Inc (NASDAQ:INNT) posted its quarterly earnings data on Monday, March, 18th. The company reported ($0.11) EPS for the quarter, meeting analysts' consensus estimates of ($0.11).

Based on aggregate information from My MarketBeat watchlists, some other companies that Innovate Biopharmaceuticals investors own include 9 Meters Biopharma (NMTR), NIO (NIO), Corbus Pharmaceuticals (CRBP), Energy Transfer (ET), Iterum Therapeutics (ITRM), Meta Platforms (META) and Micron Technology (MU).

Company Calendar

Last Earnings
3/18/2019
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:INNT
CIK
1551986
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.05 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($0.27) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8 thousand
Optionable
Not Optionable
Beta
-0.39
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:INNT) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners